Skip to content

Clinical trials

Observational Tuberous Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberous Sclerosis Phase: Observational Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20071
20081
20091
20101
20121
20131
20154
20164
20171
20182
20193
20212
20224
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting13
Active, not recruiting4
Unknown status3
Terminated2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)5
Beijing Children's Hospital3
Boston Children's Hospital2
Maastricht University Medical Center2
Assiut University1
CENTOGENE GmbH Rostock1
Children's Hospital Medical Center, Cincinnati1
David M. Ritter1
Erasmus Medical Center1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberous Sclerosis37
Lymphangioleiomyomatosis8
Epilepsy5
Neurofibromatosis 15
Autistic Disorder3
Basal Cell Nevus Syndrome3
Neurocutaneous Syndromes3
von Hippel-Lindau Disease3
Albinism2
Angiomyolipoma2

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.